31
Pieter de Haan, Henrika Gerardina Maria Poels Janssen: Solid pharmaceutical composition comprising an excipient capable of binding water. Akzo Nobel, William M Blackstone, February 13, 2001: US06187339 (15 worldwide citation)

The invention concerns a solid pharmaceutical composition comprising less than 7% by weight of an oil or oily substance, a low dosage active ingredient, and a water insoluble non-cross-linked polymeric excipient capable of binding water and having a mean particle size greater than 150 &mgr;m. The co ...


32
Pankhania Mahendra Govind, Meyer Michael Christopher: Stable solid pharmaceutical composition containing ibuprofen and codeine.. Boots Co, July 20, 1988: EP0274845-A1 (15 worldwide citation)

A solid composition comprising ibuprofen or a pharmaceutically acceptable salt thereof and codeine or a pharmaceutically acceptable salt thereof together with a sufficient amount of an insoluble salt of carboxymethylcellulose to prevent discolouration of the composition.


33
Anne Fjellestad Paulsen: Composition for oral administration of peptides. Ferring, Ostrolenk Faber Gerb & Soffen, July 14, 1998: US05780434 (13 worldwide citation)

A solid pharmaceutical composition for oral administration of small and medium size peptides, particularly vasopressin, oxytocin, and their analogues, comprises the peptide, a protease inhibitor, an enteric coat and a pharmaceutically acceptable carrier containing a buffering agent buffering at a pH ...


34
Balasingam Radhakrishnan, Diti Aggarwal, Michelle Ferro, Kenneth D James, Navdeep B Malkar, Mark A Miller, Leo Pavliv, Karen Polowy, Monica Puskas, Nnochiri N Ekwuribe: Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof. Biocon, Marianne Fuierer, Moore & Van Allen PLLC, October 20, 2009: US07605123 (12 worldwide citation)

Fatty acid compositions for administration of of pharmaceutical agents, such as proteins and peptides, protein and peptide conjugates, and/or cation-polypeptide conjugate complexes. In particular, the invention provides a solid pharmaceutical composition formulated for oral administration by ingesti ...


35
Augart Helmut, Gebhardt Uwe Dr, Herrmann Wolfgang Dr: Process for the stabilisation of a solid pharmaceutical composition comprising cyclic amino acids.. Goedecke, February 27, 1991: EP0414263-A2 (12 worldwide citation)

Cyclic amino acids of the general formula VII in which n denotes the numbers 4 to 6 and pharmaceutical preparations containing them, which are characterised in that, relative to the amino acids VII, they have a content of lactam of the general formula VIII in which n has the abovementioned meaning, ...


36
Yoshimi Hashimoto, Hiroyoshi Shiozawa, Hideyuki Kishimoto, Yoichi Setoguchi: H.sub.2 -Receptor antagonist and antacid composition. Yamaouchi Pharmaceutical, Sughrue Mion Zinn Macpeak & Seas PLLC, July 18, 2000: US06090412 (11 worldwide citation)

A solid pharmaceutical composition for oral administration comprising a histamine H.sub.2 -receptor antagonist, a low neutralizing capacity antacid, and a high neutralizing capacity antacid coated with a pH-independent and water-insoluble polymer base, which composition improves the condition of a p ...


37
Michael Bornstein, N Adeyinka Williams: Lyophilized pulmonary surfactant peptide compositions. Ortho Pharmaceutical Corporation, Kenneth J Dow, September 14, 1999: US05952303 (11 worldwide citation)

An improved solid pharmaceutical composition comprising a lyophilized liposomal KL4 pulmonary surfactant composition comprising:


38
Ronchi Celestino, Berlati Fabio, Scaglione Francesco: Montefarmaco, May 2, 1997: EP0770384-A1 (11 worldwide citation)

Anhydrous solid pharmaceutical composition for vaginal use, comprising at least one active ingredient in a mixture with conventional carriers and excipients, containing one or more muco-adhesive polymers dispersed in the carrier. These compositions allow for longer contact between the mucosa and the ...


39
De Haan Pieter, Poels Janssen Henrika Gerardin: Solid pharmaceutical composition comprising an excipient capable of binding water. Akzo Nobel, April 24, 1996: EP0707848-A1 (11 worldwide citation)

The invention concerns a solid pharmaceutical composition comprising less than 7% by weight of an oil or oily substance, a low dosage active ingredient, and a water insoluble non-cross-linked polymeric excipient capable of binding water and having a mean particle size greater than 150 mu m. The comp ...


40
Pieter de Haan, Cornelus J M van der Ven: Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer. Akzo, Mary E Gormley, August 15, 1995: US05441747 (10 worldwide citation)

Disclosed are stabilized dry chemical (e.g. pharmaceutical) compositions containing the water soluble acid addition salt of a poorly soluble basic compound (e.g. mianserin, apomorphine, chlorpromazine, imipramine, or promethazine); an excipient selected from the group consisting of microcrystalline ...